首页 > 最新文献

Journal of Clinical Medicine最新文献

英文 中文
Fetal Teratomas: Advances in Diagnosis and Management. 胎儿畸胎瘤:诊断和管理的进展。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206245
May Abiad, Nikan Zargarzadeh, Ali Javinani, Eyal Krispin, Alireza A Shamshirsaz

Fetal teratomas, though rare, represent a significant proportion of tumors arising during fetal development. These tumors arise from pluripotent cells and can present in varying degrees of severity, ranging from incidental findings to life-threatening conditions. Prenatal imaging, via ultrasound and MRI, is necessary for diagnosis and risk assessment. The management of fetal teratomas, particularly those associated with complications like hydrops or airway obstruction, often requires a multidisciplinary approach. Interventions such as ex-utero intrapartum treatment (EXIT) procedures and minimally invasive alternatives have emerged as critical tools to improve neonatal outcomes in severe cases. Despite advances in fetal therapies, careful prenatal monitoring and individualized management remain essential, especially for tumors with high vascularity or those that risk compromising cardiac output. This review explores the diagnostic methods, management strategies, and outcomes associated with fetal teratomas, highlighting recent advancements that contribute to improving survival and reducing morbidity in affected neonates.

胎儿畸胎瘤虽然罕见,但在胎儿发育过程中产生的肿瘤中占很大比例。这些肿瘤来源于多能细胞,严重程度不一,从偶然发现到危及生命不等。产前超声和核磁共振成像是诊断和风险评估的必要手段。胎儿畸胎瘤的处理,尤其是那些与水肿或气道阻塞等并发症相关的畸胎瘤,往往需要采用多学科方法。产前治疗(EXIT)程序和微创替代方法等干预措施已成为改善严重病例新生儿预后的重要工具。尽管胎儿治疗取得了进展,但仔细的产前监测和个体化管理仍然至关重要,尤其是对于高血管性肿瘤或有损害心输出量风险的肿瘤。本综述探讨了与胎儿畸胎瘤相关的诊断方法、管理策略和预后,重点介绍了有助于提高受影响新生儿存活率和降低发病率的最新进展。
{"title":"Fetal Teratomas: Advances in Diagnosis and Management.","authors":"May Abiad, Nikan Zargarzadeh, Ali Javinani, Eyal Krispin, Alireza A Shamshirsaz","doi":"10.3390/jcm13206245","DOIUrl":"https://doi.org/10.3390/jcm13206245","url":null,"abstract":"<p><p>Fetal teratomas, though rare, represent a significant proportion of tumors arising during fetal development. These tumors arise from pluripotent cells and can present in varying degrees of severity, ranging from incidental findings to life-threatening conditions. Prenatal imaging, via ultrasound and MRI, is necessary for diagnosis and risk assessment. The management of fetal teratomas, particularly those associated with complications like hydrops or airway obstruction, often requires a multidisciplinary approach. Interventions such as ex-utero intrapartum treatment (EXIT) procedures and minimally invasive alternatives have emerged as critical tools to improve neonatal outcomes in severe cases. Despite advances in fetal therapies, careful prenatal monitoring and individualized management remain essential, especially for tumors with high vascularity or those that risk compromising cardiac output. This review explores the diagnostic methods, management strategies, and outcomes associated with fetal teratomas, highlighting recent advancements that contribute to improving survival and reducing morbidity in affected neonates.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Impact of Pulmonary Diseases in 952 Patients with Thoracic and/or Abdominal Aortic Aneurysm. 952 例胸主动脉瘤和/或腹主动脉瘤患者肺部疾病的预后影响。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206247
Yoichi Kobayashi, Takashi Ishiguro, Naho Kagiyama, Makoto Sumi, Noboru Takayanagi

Background/Objectives: Pulmonary diseases are common in patients with thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Although high prevalences of chronic obstructive pulmonary disease and lung cancer (LC) are known, the prevalence of these and other pulmonary diseases regarding their relation to the outcome of TAA and/or AAA are not determined. Methods: Pulmonary diseases present at aortic aneurysm (AA) diagnosis and follow-up periods and cause of death of 952 patients with TAA, AAA, or TAA + AAA (including thoracoabdominal AA) treated at our institution in Japan were retrospectively analyzed. Cox regression analysis was used to investigate potential risk factors of mortality. Results: The mean patient age was 72.4 years, and the median follow-up was 4.92 years. At diagnosis, 528 (55.5%) patients had pulmonary diseases, including emphysema without interstitial lung disease (ILD) or LC, LC, idiopathic pulmonary fibrosis (IPF) without LC, non-IPF ILD without LC, and interstitial lung abnormalities (ILAs) without LC in 250, 85, 65, 15, and 58 patients, respectively. During follow-up, LC and acute exacerbation (AE) of IPF developed in 50 and 12 patients, respectively. In 213 patients who died, there were 45 (21.1%) aortic disease-related deaths. Other causes of death included LC (27.7%), cardiovascular events (9.4%), pneumonia (5.6%), and interstitial lung disease (4.7%). In a multivariate Cox regression hazard model, age; larger maximum aneurysm diameter; and coexisting LC, IPF, or concomitant cancer were associated with poor prognosis. Conclusions: In patients with AA, not only age and aneurysm diameter but also coexisting LC and IPF were prognostic factors for mortality.

背景/目的:肺部疾病是胸主动脉瘤(TAA)和腹主动脉瘤(AAA)患者的常见病。虽然慢性阻塞性肺疾病和肺癌(LC)的发病率很高,但这些疾病和其他肺部疾病的发病率与 TAA 和/或 AAA 结果的关系尚未确定。方法:回顾性分析在日本本院接受治疗的 952 名 TAA、AAA 或 TAA + AAA(包括胸腹型 AA)患者在主动脉瘤(AA)诊断和随访期间出现的肺部疾病以及死亡原因。采用 Cox 回归分析法研究潜在的死亡风险因素。结果:患者平均年龄为 72.4 岁,中位随访时间为 4.92 年。确诊时,528 名患者(55.5%)患有肺部疾病,包括无间质性肺病 (ILD) 或 LC 的肺气肿、LC、无 LC 的特发性肺纤维化 (IPF)、无 LC 的非 IPF ILD 以及无 LC 的肺间质异常 (ILA),患者人数分别为 250、85、65、15 和 58。在随访期间,分别有 50 名和 12 名患者出现 LC 和 IPF 急性加重(AE)。在 213 例死亡患者中,有 45 例(21.1%)与主动脉疾病相关。其他死因包括LC(27.7%)、心血管事件(9.4%)、肺炎(5.6%)和间质性肺病(4.7%)。在多变量 Cox 回归危险模型中,年龄、动脉瘤最大直径较大、并存 LC、IPF 或合并癌症与预后不良有关。结论是在 AA 患者中,不仅年龄和动脉瘤直径,而且并存的 LC 和 IPF 也是死亡率的预后因素。
{"title":"Prognostic Impact of Pulmonary Diseases in 952 Patients with Thoracic and/or Abdominal Aortic Aneurysm.","authors":"Yoichi Kobayashi, Takashi Ishiguro, Naho Kagiyama, Makoto Sumi, Noboru Takayanagi","doi":"10.3390/jcm13206247","DOIUrl":"https://doi.org/10.3390/jcm13206247","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Pulmonary diseases are common in patients with thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). Although high prevalences of chronic obstructive pulmonary disease and lung cancer (LC) are known, the prevalence of these and other pulmonary diseases regarding their relation to the outcome of TAA and/or AAA are not determined. <b>Methods:</b> Pulmonary diseases present at aortic aneurysm (AA) diagnosis and follow-up periods and cause of death of 952 patients with TAA, AAA, or TAA + AAA (including thoracoabdominal AA) treated at our institution in Japan were retrospectively analyzed. Cox regression analysis was used to investigate potential risk factors of mortality. <b>Results:</b> The mean patient age was 72.4 years, and the median follow-up was 4.92 years. At diagnosis, 528 (55.5%) patients had pulmonary diseases, including emphysema without interstitial lung disease (ILD) or LC, LC, idiopathic pulmonary fibrosis (IPF) without LC, non-IPF ILD without LC, and interstitial lung abnormalities (ILAs) without LC in 250, 85, 65, 15, and 58 patients, respectively. During follow-up, LC and acute exacerbation (AE) of IPF developed in 50 and 12 patients, respectively. In 213 patients who died, there were 45 (21.1%) aortic disease-related deaths. Other causes of death included LC (27.7%), cardiovascular events (9.4%), pneumonia (5.6%), and interstitial lung disease (4.7%). In a multivariate Cox regression hazard model, age; larger maximum aneurysm diameter; and coexisting LC, IPF, or concomitant cancer were associated with poor prognosis. <b>Conclusions:</b> In patients with AA, not only age and aneurysm diameter but also coexisting LC and IPF were prognostic factors for mortality.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508892/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Aging and Knee Osteoarthritis on Lower Limb Alignment and CPAK Classification: Gender Differences in a Japanese Cohort. 衰老和膝关节骨性关节炎对下肢对齐和 CPAK 分类的影响:日本队列中的性别差异
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206250
Kento Harada, Yu Mori, Masayuki Kamimura, Takashi Aki, Tomoki Koyama, Toshimi Aizawa

Objective: This study investigates the impact of age and knee osteoarthritis (OA) on the coronal plane alignment of the lower extremity in Japanese males and females, utilizing the Coronal Plane Alignment of the Knee (CPAK) classification system. Methods: A cross-sectional analysis was conducted with 150 male and 150 female patients. Participants were divided into three groups according to age and OA progression. The mechanical lateral distal femoral angle (mLDFA) and mechanical medial proximal tibial angle (mMPTA) were measured using standard digital long-leg radiographs. Arithmetic hip-knee-ankle angle (aHKA) and joint line obliquity (JLO) were calculated, and the CPAK classification was performed to verify the distribution among the three groups. Results: The results showed increased varus alignment of the mean mLDFA correlated with OA in both genders and with aging in males. The mean mMPTA did not change in males but shifted toward varus in females with both aging and OA. Both genders demonstrated a constitutional varus alignment with the progression of osteoarthritis (males: 1.3 ± 2.4° to -3.5 ± 3.7°, p < 0.001; females: -1.2 ± 3.2° to -3.6 ± 2.9°, p < 0.001). However, this trend with aging was observed only in females (0.0 ± 2.5° to -1.2 ± 3.2°, p = 0.018). JLO maintained its apex distal position with aging and OA progression in all subjects. The study further revealed a notable transition from CPAK Type II to Type I with OA progression in both genders, additionally influenced by aging in females. Conclusions: Aging affects coronal alignment and CPAK classification differently across genders. With OA progression, there was a shift toward smaller aHKA, while JLO remained unchanged. Compared to other races, young Japanese people exhibit similar CPAK distributions, but distinct differences appear in OA-affected individuals, highlighting potential racial variations in CPAK classifications.

研究目的本研究采用膝关节冠状面排列(CPAK)分类系统,调查年龄和膝关节骨性关节炎(OA)对日本男性和女性下肢冠状面排列的影响。研究方法对 150 名男性和 150 名女性患者进行了横断面分析。根据年龄和 OA 进展情况将参与者分为三组。使用标准数字长腿X光片测量机械股骨外侧远端角度(mLDFA)和机械胫骨内侧近端角度(mMPTA)。计算算术髋-膝-踝角度(aHKA)和关节线斜度(JLO),并进行CPAK分类以验证三组间的分布情况。结果显示结果显示,平均 mLDFA 的变位增加与男女的 OA 相关,男性的 OA 增加与年龄增长相关。男性的 mMPTA 平均值没有变化,但女性的 mMPTA 平均值则随着年龄增长和 OA 的增加而向变位方向移动。随着骨关节炎的发展,男女两性都表现出了一种惯性变位排列(男性:1.3 ± 2.4°到 -3.5 ± 3.7°,p < 0.001;女性:-1.2 ± 3.2°到 -3.6 ± 2.9°,p < 0.001)。然而,这种老化趋势仅在女性中观察到(0.0 ± 2.5° 至 -1.2 ± 3.2°,p = 0.018)。在所有受试者中,随着年龄的增长和 OA 的进展,JLO 保持其顶点远端位置。该研究进一步显示,随着 OA 的进展,男女受试者的 CPAK 均明显从 II 型向 I 型过渡,女性受试者还受到了年龄增长的影响。研究结论衰老对冠状排列和CPAK分类的影响在性别上有所不同。随着 OA 的进展,aHKA 会逐渐变小,而 JLO 则保持不变。与其他种族相比,年轻的日本人表现出相似的CPAK分布,但在受OA影响的个体中出现了明显的差异,凸显了CPAK分类中潜在的种族差异。
{"title":"Impact of Aging and Knee Osteoarthritis on Lower Limb Alignment and CPAK Classification: Gender Differences in a Japanese Cohort.","authors":"Kento Harada, Yu Mori, Masayuki Kamimura, Takashi Aki, Tomoki Koyama, Toshimi Aizawa","doi":"10.3390/jcm13206250","DOIUrl":"10.3390/jcm13206250","url":null,"abstract":"<p><p><b>Objective:</b> This study investigates the impact of age and knee osteoarthritis (OA) on the coronal plane alignment of the lower extremity in Japanese males and females, utilizing the Coronal Plane Alignment of the Knee (CPAK) classification system. <b>Methods:</b> A cross-sectional analysis was conducted with 150 male and 150 female patients. Participants were divided into three groups according to age and OA progression. The mechanical lateral distal femoral angle (mLDFA) and mechanical medial proximal tibial angle (mMPTA) were measured using standard digital long-leg radiographs. Arithmetic hip-knee-ankle angle (aHKA) and joint line obliquity (JLO) were calculated, and the CPAK classification was performed to verify the distribution among the three groups. <b>Results:</b> The results showed increased varus alignment of the mean mLDFA correlated with OA in both genders and with aging in males. The mean mMPTA did not change in males but shifted toward varus in females with both aging and OA. Both genders demonstrated a constitutional varus alignment with the progression of osteoarthritis (males: 1.3 ± 2.4° to -3.5 ± 3.7°, <i>p</i> < 0.001; females: -1.2 ± 3.2° to -3.6 ± 2.9°, <i>p</i> < 0.001). However, this trend with aging was observed only in females (0.0 ± 2.5° to -1.2 ± 3.2°, <i>p</i> = 0.018). JLO maintained its apex distal position with aging and OA progression in all subjects. The study further revealed a notable transition from CPAK Type II to Type I with OA progression in both genders, additionally influenced by aging in females. <b>Conclusions:</b> Aging affects coronal alignment and CPAK classification differently across genders. With OA progression, there was a shift toward smaller aHKA, while JLO remained unchanged. Compared to other races, young Japanese people exhibit similar CPAK distributions, but distinct differences appear in OA-affected individuals, highlighting potential racial variations in CPAK classifications.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review of the Adjuvant Combinations Journey. 乳腺癌辅助放疗和化疗排序:序贯、伴随还是其他?全面回顾辅助联合疗法之旅。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206251
Grazia Lazzari, Antonietta Montagna, Barbara D'Andrea, Antonella Bianculli, Giovanni Calice, Raffaele Tucciariello, Giovanni Castaldo, Vito Metallo, Giuseppina De Marco, Ilaria Benevento

Background: To date, in breast cancer (BC) treatment, adjuvant chemotherapy (A-CT) has preceded adjuvant radiotherapy (A-RT). In the last twenty years, the adjuvant treatment of BC has quickly evolved due to better knowledge of its molecular biology, genetic profile, and α/β ratio of 3/4 Gy for tumor and normal tissue radiosensitivity. Thus, new schedules with hypofractionated radiotherapy have been tested, and a third generation of A-CT has been introduced, raising the question of whether it is time to rethink the sequencing between these two approaches. Methods: In the last 20 years, many attempts have been made worldwide to optimize the best sequencing strategy between these two approaches in terms of sequential CT-RT and RT-CT and concomitant and sandwich modalities using drugs and schedules. This paper presents a comprehensive review of the state of the art, analyzing all the available studies to assess the sequencing between A-CT and A-RT with different generations of chemotherapy schedules. Results: More than 8000 patients from 30 studies treated with adjuvant chemotherapy and whole breast radiotherapy who were enrolled in randomized, retrospective, and prospective studies were analyzed. Sequential, concomitant, and sandwich modalities of chemotherapy with conventional or hypofractionated RT schedules from the most important studies were included. The most used sequence was adjuvant chemotherapy followed by conventional or hypofractionated radiotherapy. In the concomitant approach, i.v. CMF has been the most important adopted schedule, while the concomitant use of anthracyclines and taxanes with conventional or hypofractionated radiotherapy has been found to be more toxic. One study analyzed the benefit in terms of reducing adjuvant treatment time with upfront hypofractionated radiotherapy and third-generation chemotherapy. Conclusions: At present, the best sequencing strategy has not yet been defined. This comprehensive review is a journey among the most important randomized, retrospective, and prospective studies that highlights the past, current, and novel time sequencing proposals between A-CT and A-RT to assess the state of the art and provide useful information for future adjuvant approaches in breast cancer treatment.

背景:迄今为止,在乳腺癌(BC)治疗中,辅助化疗(A-CT)一直先于辅助放疗(A-RT)。在过去的二十年中,由于对乳腺癌的分子生物学、遗传特征以及肿瘤和正常组织放射敏感性的 3/4 Gy α/β 比值有了更深入的了解,乳腺癌的辅助治疗得到了快速发展。因此,新的低分次放疗计划已通过测试,第三代 A-CT 也已问世,这就提出了一个问题:是否是时候重新考虑这两种方法之间的排序了?方法:在过去的 20 年中,世界范围内进行了许多尝试,以优化这两种方法之间的最佳排序策略,包括顺序 CT-RT 和 RT-CT,以及使用药物和计划的同时和三明治模式。本文对该领域的现状进行了全面回顾,分析了所有可用的研究,以评估 A-CT 和 A-RT 与不同代化疗方案之间的排序。研究结果分析了来自 30 项研究的 8000 多名接受辅助化疗和全乳腺放疗的患者,这些患者参加了随机、回顾性和前瞻性研究。最重要的研究中包括了化疗与常规或低分次 RT 计划的序贯、并行和三明治模式。最常用的顺序是先辅助化疗,再进行常规或低分量放疗。在同时进行的方法中,静脉注射CMF是最重要的采用方案,而同时使用蒽环类和类固醇类药物与常规或低剂量放疗的毒性更大。一项研究分析了前期低分量放疗和第三代化疗在缩短辅助治疗时间方面的益处。结论:目前,最佳的排序策略尚未确定。本综合综述是对最重要的随机、回顾性和前瞻性研究的一次探索,重点介绍了 A-CT 和 A-RT 之间过去、现在和新的时间排序建议,以评估目前的技术水平,并为未来的乳腺癌辅助治疗方法提供有用信息。
{"title":"Breast Cancer Adjuvant Radiotherapy and Chemotherapy Sequencing: Sequential, Concomitant, or What Else? A Comprehensive Review of the Adjuvant Combinations Journey.","authors":"Grazia Lazzari, Antonietta Montagna, Barbara D'Andrea, Antonella Bianculli, Giovanni Calice, Raffaele Tucciariello, Giovanni Castaldo, Vito Metallo, Giuseppina De Marco, Ilaria Benevento","doi":"10.3390/jcm13206251","DOIUrl":"10.3390/jcm13206251","url":null,"abstract":"<p><p><b>Background:</b> To date, in breast cancer (BC) treatment, adjuvant chemotherapy (A-CT) has preceded adjuvant radiotherapy (A-RT). In the last twenty years, the adjuvant treatment of BC has quickly evolved due to better knowledge of its molecular biology, genetic profile, and α/β ratio of 3/4 Gy for tumor and normal tissue radiosensitivity. Thus, new schedules with hypofractionated radiotherapy have been tested, and a third generation of A-CT has been introduced, raising the question of whether it is time to rethink the sequencing between these two approaches. <b>Methods:</b> In the last 20 years, many attempts have been made worldwide to optimize the best sequencing strategy between these two approaches in terms of sequential CT-RT and RT-CT and concomitant and sandwich modalities using drugs and schedules. This paper presents a comprehensive review of the state of the art, analyzing all the available studies to assess the sequencing between A-CT and A-RT with different generations of chemotherapy schedules. <b>Results:</b> More than 8000 patients from 30 studies treated with adjuvant chemotherapy and whole breast radiotherapy who were enrolled in randomized, retrospective, and prospective studies were analyzed. Sequential, concomitant, and sandwich modalities of chemotherapy with conventional or hypofractionated RT schedules from the most important studies were included. The most used sequence was adjuvant chemotherapy followed by conventional or hypofractionated radiotherapy. In the concomitant approach, i.v. CMF has been the most important adopted schedule, while the concomitant use of anthracyclines and taxanes with conventional or hypofractionated radiotherapy has been found to be more toxic. One study analyzed the benefit in terms of reducing adjuvant treatment time with upfront hypofractionated radiotherapy and third-generation chemotherapy. <b>Conclusions:</b> At present, the best sequencing strategy has not yet been defined. This comprehensive review is a journey among the most important randomized, retrospective, and prospective studies that highlights the past, current, and novel time sequencing proposals between A-CT and A-RT to assess the state of the art and provide useful information for future adjuvant approaches in breast cancer treatment.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression, Anxiety, and Stress Symptoms Among Students in Croatia During the COVID-19 Pandemic: A Systematic Review. 克罗地亚学生在 COVID-19 大流行期间的抑郁、焦虑和压力症状:系统回顾
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206240
Stipe Vidović, Slavica Kotromanović, Zenon Pogorelić

Background: The COVID-19 pandemic has led to an increased fear of infection, social isolation, financial concerns, and feelings of loneliness and uncertainty. Studies reveal that the pandemic has had a significant negative impact on mental health. This systematic review aimed to investigate the prevalence of depression, anxiety, and stress symptoms among students in Croatia during the COVID-19 pandemic. Methods: A systematic review was conducted following PRISMA guidelines. A literature search was performed on August 5, 2024, using the electronic databases Scopus, PubMed, Web of Science, and PsycINFO. The search utilized the Boolean logical operator expression ('depression' AND 'anxiety' AND 'stress' AND 'COVID-19' AND 'Croatia' AND 'student'). Results: Out of one hundred and fifty-four identified studies, five met the inclusion criteria and were included in the review. The studies used the Generalized Anxiety Disorder 7-item scale (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), and the Depression, Anxiety, and Stress Scale-21 (DASS-21) to assess mental health. The results indicate a high prevalence of symptoms of depression, anxiety, and stress among students in Croatia during the pandemic. Conclusion: A high prevalence of negative affective emotions was observed among students in Croatia during the pandemic. This finding underscores the importance of developing effective strategies for the early identification and management of mental disorders among students, irrespective of the pandemic's conclusion.

背景:COVID-19 大流行导致人们对感染的恐惧、社会隔离、经济担忧以及孤独感和不确定性增加。研究表明,大流行病对心理健康产生了严重的负面影响。本系统综述旨在调查 COVID-19 大流行期间克罗地亚学生中抑郁、焦虑和压力症状的发生率。方法:按照 PRISMA 指南进行了系统性综述。于 2024 年 8 月 5 日使用 Scopus、PubMed、Web of Science 和 PsycINFO 等电子数据库进行了文献检索。检索使用了布尔逻辑运算表达式("抑郁"、"焦虑"、"压力"、"COVID-19"、"克罗地亚"、"学生")。结果:在已确定的 154 项研究中,有 5 项符合纳入标准并被纳入综述。这些研究使用广泛焦虑症 7 项量表(GAD-7)、患者健康问卷-9(PHQ-9)和抑郁、焦虑和压力量表-21(DASS-21)来评估心理健康。结果表明,在大流行病期间,克罗地亚学生中抑郁、焦虑和压力症状的发生率很高。结论在大流行病期间,克罗地亚学生中消极情绪的发生率很高。这一发现强调了制定有效战略的重要性,无论大流行病的结论如何,都要及早识别和管理学生中的精神障碍。
{"title":"Depression, Anxiety, and Stress Symptoms Among Students in Croatia During the COVID-19 Pandemic: A Systematic Review.","authors":"Stipe Vidović, Slavica Kotromanović, Zenon Pogorelić","doi":"10.3390/jcm13206240","DOIUrl":"https://doi.org/10.3390/jcm13206240","url":null,"abstract":"<p><p><b>Background:</b> The COVID-19 pandemic has led to an increased fear of infection, social isolation, financial concerns, and feelings of loneliness and uncertainty. Studies reveal that the pandemic has had a significant negative impact on mental health. This systematic review aimed to investigate the prevalence of depression, anxiety, and stress symptoms among students in Croatia during the COVID-19 pandemic. <b>Methods:</b> A systematic review was conducted following PRISMA guidelines. A literature search was performed on August 5, 2024, using the electronic databases Scopus, PubMed, Web of Science, and PsycINFO. The search utilized the Boolean logical operator expression ('depression' AND 'anxiety' AND 'stress' AND 'COVID-19' AND 'Croatia' AND 'student'). <b>Results:</b> Out of one hundred and fifty-four identified studies, five met the inclusion criteria and were included in the review. The studies used the Generalized Anxiety Disorder 7-item scale (GAD-7), the Patient Health Questionnaire-9 (PHQ-9), and the Depression, Anxiety, and Stress Scale-21 (DASS-21) to assess mental health. The results indicate a high prevalence of symptoms of depression, anxiety, and stress among students in Croatia during the pandemic. <b>Conclusion:</b> A high prevalence of negative affective emotions was observed among students in Croatia during the pandemic. This finding underscores the importance of developing effective strategies for the early identification and management of mental disorders among students, irrespective of the pandemic's conclusion.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508580/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing Clinical Practice: The Potential of Multimodal Technology in Modern Medicine. 推进临床实践:多模态技术在现代医学中的潜力。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206246
Yaara Artsi, Vera Sorin, Benjamin S Glicksberg, Girish N Nadkarni, Eyal Klang

Multimodal technology is poised to revolutionize clinical practice by integrating artificial intelligence with traditional diagnostic modalities. This evolution traces its roots from Hippocrates' humoral theory to the use of sophisticated AI-driven platforms that synthesize data across multiple sensory channels. The interplay between historical medical practices and modern technology challenges conventional patient-clinician interactions and redefines diagnostic accuracy. Highlighting applications from neurology to radiology, the potential of multimodal technology emerges, suggesting a future where AI not only supports but enhances human sensory inputs in medical diagnostics. This shift invites the medical community to navigate the ethical, practical, and technological changes reshaping the landscape of clinical medicine.

多模态技术将人工智能与传统诊断模式相结合,有望彻底改变临床实践。这一演变的根源可以追溯到希波克拉底的体液理论,以及使用复杂的人工智能驱动平台综合多种感官渠道的数据。历史悠久的医疗实践与现代技术之间的相互作用挑战着传统的病人与医生之间的互动,并重新定义了诊断的准确性。通过强调从神经学到放射学的应用,多模态技术的潜力显现出来,表明在未来,人工智能不仅能支持而且能增强医疗诊断中的人类感官输入。这一转变要求医学界引导伦理、实践和技术变革,重塑临床医学的格局。
{"title":"Advancing Clinical Practice: The Potential of Multimodal Technology in Modern Medicine.","authors":"Yaara Artsi, Vera Sorin, Benjamin S Glicksberg, Girish N Nadkarni, Eyal Klang","doi":"10.3390/jcm13206246","DOIUrl":"https://doi.org/10.3390/jcm13206246","url":null,"abstract":"<p><p>Multimodal technology is poised to revolutionize clinical practice by integrating artificial intelligence with traditional diagnostic modalities. This evolution traces its roots from Hippocrates' humoral theory to the use of sophisticated AI-driven platforms that synthesize data across multiple sensory channels. The interplay between historical medical practices and modern technology challenges conventional patient-clinician interactions and redefines diagnostic accuracy. Highlighting applications from neurology to radiology, the potential of multimodal technology emerges, suggesting a future where AI not only supports but enhances human sensory inputs in medical diagnostics. This shift invites the medical community to navigate the ethical, practical, and technological changes reshaping the landscape of clinical medicine.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study. 肾功能与使用地诺单抗治疗的绝经后骨质疏松妇女的骨矿物质密度变化有关:一项回顾性队列研究的数据。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206239
Antonino Catalano, Cecilia Oliveri, Giuseppe Natale, Rita Maria Agostino, Giovanni Squadrito, Agostino Gaudio, Guido Gembillo, Djordje Marina, Valeria Cernaro, Elisa Longhitano, Giorgio Basile, Nunziata Morabito, Domenico Santoro

Background/Objectives: Renal function influences bone metabolism, as kidney failure can increase the risk of fractures. Denosumab is an approved osteoporosis treatment, but its efficacy in relation to renal function has not yet been studied in real-life scenarios. This study aimed to investigate the denosumab-induced change in bone mineral density (BMD) according to kidney function. Methods: A retrospective analysis was conducted at the outpatient clinic in postmenopausal women receiving denosumab (60 mg subcutaneously administered every 6 months). The glomerular filtration rate (eGFR) was measured by the 2021 CKD-EPI equation and patients were stratified for eGFR categories. BMD was measured by dual-energy X-ray absorptiometry. Results: 128 women (mean age 70.3 ± 9.4 years) were recruited. The mean denosumab treatment duration was 3.9 ± 1.4 years and all the participants had improved BMD values. In stepwise multiple regression analysis-after controlling for age, BMI, and treatment duration-the eGFR value (ß = -0.11, SE 0.04, p = 0.01) was independently associated with the lumbar spine BMD change. The same association remained when the eGFR categories were considered (ß = 3.564, SE 1.29, p = 0.007). In addition, after controlling for BMI and the duration of denosumab treatment, age (ß = -0.7915, SE 0.37, p = 0.03) and eGFR (ß = -0.3257, SE 0.1567, p = 0.04) were found to be associated with femoral neck BMD change. The association remained when considering eGFR categories (ß = 8.7339, SE 4.29, p = 0.04). Conclusions: This retrospective study suggests that eGFR is associated with denosumab efficacy in postmenopausal women treated for osteoporosis.

背景/目的:肾功能会影响骨代谢,因为肾功能衰竭会增加骨折风险。地诺单抗是一种已获批准的骨质疏松症治疗药物,但其疗效与肾功能的关系尚未在现实生活中进行研究。本研究旨在根据肾功能调查地诺单抗引起的骨矿物质密度(BMD)变化。研究方法在门诊对接受地诺单抗(每 6 个月皮下注射 60 毫克)治疗的绝经后妇女进行了回顾性分析。肾小球滤过率(eGFR)通过 2021 CKD-EPI 公式进行测量,并根据 eGFR 类别对患者进行分层。采用双能 X 射线吸收测量法测量 BMD。结果共招募了 128 名女性(平均年龄为 70.3 ± 9.4 岁)。地诺单抗的平均治疗时间为 3.9 ± 1.4 年,所有参与者的 BMD 值均有所改善。在逐步多元回归分析中,在控制了年龄、体重指数和治疗时间后,eGFR 值(ß = -0.11,SE 0.04,p = 0.01)与腰椎 BMD 变化独立相关。当考虑到 eGFR 类别时,这种关联仍然存在(ß = 3.564,SE 1.29,p = 0.007)。此外,在控制体重指数和地诺单抗治疗时间后,年龄(ß = -0.7915,SE 0.37,p = 0.03)和 eGFR(ß = -0.3257,SE 0.1567,p = 0.04)与股骨颈 BMD 变化相关。当考虑到 eGFR 类别时,这种关联仍然存在(ß = 8.7339,SE 4.29,p = 0.04)。结论:这项回顾性研究表明,在治疗骨质疏松症的绝经后妇女中,eGFR 与地诺单抗的疗效有关。
{"title":"Renal Function Is Associated with Changes in Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Denosumab: Data From a Retrospective Cohort Study.","authors":"Antonino Catalano, Cecilia Oliveri, Giuseppe Natale, Rita Maria Agostino, Giovanni Squadrito, Agostino Gaudio, Guido Gembillo, Djordje Marina, Valeria Cernaro, Elisa Longhitano, Giorgio Basile, Nunziata Morabito, Domenico Santoro","doi":"10.3390/jcm13206239","DOIUrl":"10.3390/jcm13206239","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Renal function influences bone metabolism, as kidney failure can increase the risk of fractures. Denosumab is an approved osteoporosis treatment, but its efficacy in relation to renal function has not yet been studied in real-life scenarios. This study aimed to investigate the denosumab-induced change in bone mineral density (BMD) according to kidney function. <b>Methods</b>: A retrospective analysis was conducted at the outpatient clinic in postmenopausal women receiving denosumab (60 mg subcutaneously administered every 6 months). The glomerular filtration rate (eGFR) was measured by the 2021 CKD-EPI equation and patients were stratified for eGFR categories. BMD was measured by dual-energy X-ray absorptiometry. <b>Results</b>: 128 women (mean age 70.3 ± 9.4 years) were recruited. The mean denosumab treatment duration was 3.9 ± 1.4 years and all the participants had improved BMD values. In stepwise multiple regression analysis-after controlling for age, BMI, and treatment duration-the eGFR value (ß = -0.11, SE 0.04, <i>p</i> = 0.01) was independently associated with the lumbar spine BMD change. The same association remained when the eGFR categories were considered (ß = 3.564, SE 1.29, <i>p</i> = 0.007). In addition, after controlling for BMI and the duration of denosumab treatment, age (ß = -0.7915, SE 0.37, <i>p</i> = 0.03) and eGFR (ß = -0.3257, SE 0.1567, <i>p</i> = 0.04) were found to be associated with femoral neck BMD change. The association remained when considering eGFR categories (ß = 8.7339, SE 4.29, <i>p</i> = 0.04). <b>Conclusions</b>: This retrospective study suggests that eGFR is associated with denosumab efficacy in postmenopausal women treated for osteoporosis.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11514604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescribing Hydroxyurea in Sickle Cell Disease Patients: The Pattern and Association with Co-Prescribed Medications Used to Manage the Disease Complications. 镰状细胞病患者的羟基脲处方:镰状细胞病患者使用羟基脲的模式及其与用于治疗疾病并发症的联合处方药物之间的关联。
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206254
Nida Alsaffar, Mohammed Ali Alsaleh, Abdulmonem Ali Alsaleh, Neda Z Ghanem, Mohammad Hussain Al Khamees, Mohammed A Alqurain, Jenan Almatouq, Bader AlAlwan, Aymen A Alqurain

Background and Objectives: Hydroxyurea (HU) is an effective medication used to reduce the frequency of painful crises associated with sickle cell disease (SCD). However, data describing its prevalence among SCD patients in the Eastern Region of Saudi Arabia are scarce. This is a multi-center, retrospective, cross-sectional study that aims to investigate the pattern of prescribing HU in SCD patients and to determine the association between prescribing HU and other co-prescribed medications used to manage SCD complications. Methods: Data were collected from patients who visited the hematology clinics of Al-Qatif Central Hospital (QCH) and King Fahad Hospital in Hofuf (KFHH) between June 2021 to May 2023. The data included demographics, prescribed medications, and recent laboratory test results, all of which were collected from patients' medical records. Descriptive statistics were utilized to assess the difference between HU users vs. non-users. A binary logistic regression model was used to determine the association between prescribing HU and co-prescribed medications used to manage SCD complications. The results are presented as the odds ratio (OR) and 95% confidence interval (95% CI). Results: This study included 2816 SCD patients with a 56% prevalence of HU prescription. HU was prescribed for young age groups more often compared to old age group patients. Young males were more likely to be prescribed with HU compared to females, and it becomes dominant in females after the age of 36. HU users were more likely to have paracetamol (69% vs. 53%, OR = 1.9, 95% CI 1.6-2.2), NSAIDs (50% vs. 35%, OR = 1.7, 95% CI 1.5-2), and opioids (41% vs. 37%, OR = 1.3, 95% CI 1.1-1.6) co-prescribed, and less often to have laxatives (8% vs. 5%, OR = 0.66, 95% CI 0.48-0.9) and anticoagulants (22% vs. 15%, OR = 0.56, 95% CI 0.46-0.68) co-prescribed compared to non-users. Conclusions: The pattern of prescribing HU, supported by the association findings, raises concerns about patients' compliance and adherence to HU therapy. Early health education, specifically to young female SCD patients, is warranted to increase the success rate of HU therapy.

背景和目的:羟基脲(HU)是一种有效的药物,可用于减少镰状细胞病(SCD)相关疼痛性危象的发生频率。然而,在沙特阿拉伯东部地区,描述镰状细胞病(SCD)患者使用该药物情况的数据却很少。这是一项多中心、回顾性、横断面研究,旨在调查 SCD 患者开具 HU 处方的模式,并确定开具 HU 处方与用于控制 SCD 并发症的其他联合处方药物之间的关联。研究方法收集了2021年6月至2023年5月期间前往卡提夫中心医院(QCH)和霍夫夫法赫德国王医院(KFHH)血液科门诊就诊的患者的数据。数据包括人口统计学特征、处方药物和最近的化验结果,所有这些都是从患者病历中收集的。利用描述性统计来评估HU使用者与非使用者之间的差异。二元逻辑回归模型用于确定开具 HU 处方与用于控制 SCD 并发症的联合处方药物之间的关联。结果以几率比(OR)和 95% 置信区间(95% CI)表示。结果:该研究纳入了 2816 名 SCD 患者,HU 处方的使用率为 56%。与老年患者相比,处方 HU 的年轻群体更多。与女性相比,年轻男性更有可能被处方 HU,而女性在 36 岁以后则成为 HU 的主要使用者。使用 HU 的患者更有可能同时服用扑热息痛(69% 对 53%,OR = 1.9,95% CI 1.6-2.2)、非甾体抗炎药(50% 对 35%,OR = 1.7,95% CI 1.5-2)和阿片类药物(41% 对 37%,OR = 1.3,95% CI 1.1-1.6)。6),而与非使用者相比,联合处方泻药(8% vs. 5%,OR = 0.66,95% CI 0.48-0.9)和抗凝剂(22% vs. 15%,OR = 0.56,95% CI 0.46-0.68)的情况较少。结论HU的处方模式得到了相关研究结果的支持,这引起了人们对患者对HU治疗的依从性和坚持性的关注。有必要对年轻的女性 SCD 患者进行早期健康教育,以提高 HU 治疗的成功率。
{"title":"Prescribing Hydroxyurea in Sickle Cell Disease Patients: The Pattern and Association with Co-Prescribed Medications Used to Manage the Disease Complications.","authors":"Nida Alsaffar, Mohammed Ali Alsaleh, Abdulmonem Ali Alsaleh, Neda Z Ghanem, Mohammad Hussain Al Khamees, Mohammed A Alqurain, Jenan Almatouq, Bader AlAlwan, Aymen A Alqurain","doi":"10.3390/jcm13206254","DOIUrl":"10.3390/jcm13206254","url":null,"abstract":"<p><p><b>Background and Objectives:</b> Hydroxyurea (HU) is an effective medication used to reduce the frequency of painful crises associated with sickle cell disease (SCD). However, data describing its prevalence among SCD patients in the Eastern Region of Saudi Arabia are scarce. This is a multi-center, retrospective, cross-sectional study that aims to investigate the pattern of prescribing HU in SCD patients and to determine the association between prescribing HU and other co-prescribed medications used to manage SCD complications. <b>Methods:</b> Data were collected from patients who visited the hematology clinics of Al-Qatif Central Hospital (QCH) and King Fahad Hospital in Hofuf (KFHH) between June 2021 to May 2023. The data included demographics, prescribed medications, and recent laboratory test results, all of which were collected from patients' medical records. Descriptive statistics were utilized to assess the difference between HU users vs. non-users. A binary logistic regression model was used to determine the association between prescribing HU and co-prescribed medications used to manage SCD complications. The results are presented as the odds ratio (OR) and 95% confidence interval (95% CI). <b>Results:</b> This study included 2816 SCD patients with a 56% prevalence of HU prescription. HU was prescribed for young age groups more often compared to old age group patients. Young males were more likely to be prescribed with HU compared to females, and it becomes dominant in females after the age of 36. HU users were more likely to have paracetamol (69% vs. 53%, OR = 1.9, 95% CI 1.6-2.2), NSAIDs (50% vs. 35%, OR = 1.7, 95% CI 1.5-2), and opioids (41% vs. 37%, OR = 1.3, 95% CI 1.1-1.6) co-prescribed, and less often to have laxatives (8% vs. 5%, OR = 0.66, 95% CI 0.48-0.9) and anticoagulants (22% vs. 15%, OR = 0.56, 95% CI 0.46-0.68) co-prescribed compared to non-users. <b>Conclusions:</b> The pattern of prescribing HU, supported by the association findings, raises concerns about patients' compliance and adherence to HU therapy. Early health education, specifically to young female SCD patients, is warranted to increase the success rate of HU therapy.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508296/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Value of Monocyte-To-Lymphocyte Ratio in Differentiating Heart Failure with Reduced Ejection Fraction in Patients with Severe Aortic Stenosis-A Retrospective Analysis. 单核细胞-淋巴细胞比值在鉴别重度主动脉瓣狭窄患者射血分数降低型心力衰竭中的预测价值--回顾性分析
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206249
Anna Olasińska-Wiśniewska, Tomasz Urbanowicz, Bartłomiej Perek, Marcin Misterski, Kajetan Grodecki, Marek Grygier, Ewa Straburzyńska-Migaj, Marek Jemielity

Background/Objectives: Advanced calcific aortic stenosis, with or without coronary artery disease [CAD], may lead to severe systolic dysfunction. The aim of the study was to reveal clinical and laboratory parameters that may differentiate patients with severe aortic stenosis with and without systolic dysfunction. Methods: A retrospective, single-center study included all consecutive patients diagnosed with severe aortic stenosis with overt heart failure. Patients with hematological and neoplastic diseases were excluded. Demographic, clinical and laboratory data were analysed. Neutrophil-to-lymphocyte [NLR], monocyte-to-lymphocyte [MLR], and platelet-to-lymphocyte [PLR] ratios were calculated. The study group was divided based on left ventricular ejection fraction [LVEF]. Results: The final study population comprised 301 patients [133 males [44%]; median [Q1-3] age of 80 [75-83] years]. Co-morbidities included CAD [48.8%], arterial hypertension [75.4%], diabetes mellitus [n = 124, 41.2%], atrial fibrillation [39.2%], chronic kidney disease [60.8%]. Fifty-seven patients presented with LVEF ≤ 40% (heart failure with reduced ejection fraction (HFrEF)) and 244 with LVEF > 40%. In the multivariable analysis, N-terminal pro-B-type natriuretic peptide [NTproBNP] [p < 0.001, OR 1.000, 95%CI 1.000-1.000], baseline MLR [p < 0.020, OR 7.393, 95%CI 1.363-40.091] and female sex [p < 0.001, OR 0.308, 95%CI 0.160-0.593] were revealed as significant predictors of HFrEF. Baseline MLR weakly correlated with EuroScore II [Spearman r = 0.141, p = 0.015] and NTproBNP [r = 0.142, p = 0.014]. Cut-off values were established as 0.36 for MLR and 3927 pg/mL for NTproBNP. After excluding 147 patients with CAD, there was still a statistically significant difference in MLR between the subgroups [p = 0.024]. Conclusions: Increased values of MLR and NTproBNP together with female sex are predictive parameters for LVEF ≤ 40% in patients with severe aortic stenosis.

背景/目的:伴有或不伴有冠状动脉疾病(CAD)的晚期钙化性主动脉瓣狭窄可导致严重的收缩功能障碍。本研究旨在揭示可区分伴有或不伴有收缩功能障碍的重度主动脉瓣狭窄患者的临床和实验室参数。研究方法这是一项回顾性的单中心研究,纳入了所有连续确诊为重度主动脉瓣狭窄并伴有明显心衰的患者。血液病和肿瘤疾病患者除外。对人口统计学、临床和实验室数据进行了分析。计算了中性粒细胞对淋巴细胞比率(NLR)、单核细胞对淋巴细胞比率(MLR)和血小板对淋巴细胞比率(PLR)。根据左心室射血分数[LVEF]划分研究组。结果:最终研究对象包括 301 名患者[133 名男性[44%];中位数[Q1-3]年龄为 80 [75-83] 岁]。合并疾病包括 CAD [48.8%]、动脉高血压 [75.4%]、糖尿病 [n = 124,41.2%]、心房颤动 [39.2%]、慢性肾病 [60.8%]。57名患者的LVEF≤40%(射血分数降低型心衰(HFrEF)),244名患者的LVEF>40%。在多变量分析中,N末端前B型钠尿肽[NTproBNP] [p < 0.001, OR 1.000, 95%CI 1.000-1.000]、基线MLR[p < 0.020, OR 7.393, 95%CI 1.363-40.091]和女性性别[p < 0.001, OR 0.308, 95%CI 0.160-0.593]是预测HFrEF的重要因素。基线 MLR 与 EuroScore II [Spearman r = 0.141,p = 0.015] 和 NTproBNP [r = 0.142,p = 0.014] 呈弱相关。MLR 和 NTproBNP 的临界值分别为 0.36 和 3927 pg/mL。在排除 147 名患有 CAD 的患者后,亚组之间的 MLR 仍有显著的统计学差异 [p = 0.024]。结论:MLR 和 NTproBNP 值的升高以及女性性别是严重主动脉瓣狭窄患者 LVEF ≤ 40% 的预测参数。
{"title":"Predictive Value of Monocyte-To-Lymphocyte Ratio in Differentiating Heart Failure with Reduced Ejection Fraction in Patients with Severe Aortic Stenosis-A Retrospective Analysis.","authors":"Anna Olasińska-Wiśniewska, Tomasz Urbanowicz, Bartłomiej Perek, Marcin Misterski, Kajetan Grodecki, Marek Grygier, Ewa Straburzyńska-Migaj, Marek Jemielity","doi":"10.3390/jcm13206249","DOIUrl":"https://doi.org/10.3390/jcm13206249","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Advanced calcific aortic stenosis, with or without coronary artery disease [CAD], may lead to severe systolic dysfunction. The aim of the study was to reveal clinical and laboratory parameters that may differentiate patients with severe aortic stenosis with and without systolic dysfunction. <b>Methods</b>: A retrospective, single-center study included all consecutive patients diagnosed with severe aortic stenosis with overt heart failure. Patients with hematological and neoplastic diseases were excluded. Demographic, clinical and laboratory data were analysed. Neutrophil-to-lymphocyte [NLR], monocyte-to-lymphocyte [MLR], and platelet-to-lymphocyte [PLR] ratios were calculated. The study group was divided based on left ventricular ejection fraction [LVEF]. <b>Results</b>: The final study population comprised 301 patients [133 males [44%]; median [Q1-3] age of 80 [75-83] years]. Co-morbidities included CAD [48.8%], arterial hypertension [75.4%], diabetes mellitus [n = 124, 41.2%], atrial fibrillation [39.2%], chronic kidney disease [60.8%]. Fifty-seven patients presented with LVEF ≤ 40% (heart failure with reduced ejection fraction (HFrEF)) and 244 with LVEF > 40%. In the multivariable analysis, N-terminal pro-B-type natriuretic peptide [NTproBNP] [<i>p</i> < 0.001, OR 1.000, 95%CI 1.000-1.000], baseline MLR [<i>p</i> < 0.020, OR 7.393, 95%CI 1.363-40.091] and female sex [<i>p</i> < 0.001, OR 0.308, 95%CI 0.160-0.593] were revealed as significant predictors of HFrEF. Baseline MLR weakly correlated with EuroScore II [Spearman r = 0.141, <i>p</i> = 0.015] and NTproBNP [r = 0.142, <i>p</i> = 0.014]. Cut-off values were established as 0.36 for MLR and 3927 pg/mL for NTproBNP. After excluding 147 patients with CAD, there was still a statistically significant difference in MLR between the subgroups [<i>p</i> = 0.024]. <b>Conclusions</b>: Increased values of MLR and NTproBNP together with female sex are predictive parameters for LVEF ≤ 40% in patients with severe aortic stenosis.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A New Tool for Extracting Static and Dynamic Parameters from [18F]F-DOPA PET/CT in Pediatric Gliomas. 从小儿胶质瘤 [18F]F-DOPA PET/CT 中提取静态和动态参数的新工具
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-19 DOI: 10.3390/jcm13206252
Michele Mureddu, Thomas Funck, Giovanni Morana, Andrea Rossi, Antonia Ramaglia, Claudia Milanaccio, Antonio Verrico, Gianluca Bottoni, Francesco Fiz, Arnoldo Piccardo, Marco Massimo Fato, Rosella Trò

Background/Objectives: PET imaging with [18F]F-DOPA has demonstrated high potential for the evaluation and management of pediatric brain gliomas. Manual extraction of PET parameters is time-consuming, lacks reproducibility, and varies with operator experience. Methods: In this study, we tested whether a semi-automated image processing framework could overcome these limitations. Pediatric patients with available static and/or dynamic [18F]F-DOPA PET studies were evaluated retrospectively. We developed a Python software to automate clinical index calculations, including preprocessing to delineate tumor volumes from structural MRI, accounting for lesions with low [18F]F-DOPA uptake. A total of 73 subjects with treatment-naïve low- and high-grade gliomas, who underwent brain MRI within two weeks of [18F]F-DOPA PET, were included and analyzed. Static analysis was conducted on all subjects, while dynamic analysis was performed on 32 patients. Results: For 68 subjects, the Intraclass Correlation Coefficient for T/S between manual and ground truth segmentation was 0.91. Using our tool, ICC improved to 0.94. Our method demonstrated good reproducibility in extracting static tumor-to-striatum ratio (p = 0.357); however, significant differences were observed in tumor slope (p < 0.05). No significant differences were found in time-to-peak (p = 0.167) and striatum slope (p = 0.36). Conclusions: Our framework aids in analyzing [18F]F-DOPA PET images of pediatric brain tumors by automating clinical score extraction, simplifying segmentation and Time Activity Curve extraction, reducing user variability, and enhancing reproducibility.

背景/目的:[18F]F-DOPA正电子发射计算机断层成像在评估和治疗小儿脑胶质瘤方面具有很大的潜力。手动提取 PET 参数耗时长、缺乏可重复性,而且会因操作者的经验而异。方法:在这项研究中,我们测试了半自动图像处理框架能否克服这些局限性。我们对进行了静态和/或动态 [18F]F-DOPA PET 研究的儿科患者进行了回顾性评估。我们开发了一个 Python 软件来自动计算临床指数,包括从结构性 MRI 划分肿瘤体积的预处理,同时考虑到[18F]F-DOPA 摄取较低的病灶。共纳入并分析了73名患有低级别和高级别胶质瘤且未经治疗的受试者,这些受试者在[18F]F-DOPA PET两周内接受了脑磁共振成像检查。对所有受试者进行了静态分析,对 32 名患者进行了动态分析。结果:在 68 名受试者中,人工和地面实况分割的 T/S 级内相关系数为 0.91。使用我们的工具后,ICC 提高到了 0.94。我们的方法在提取静态肿瘤与骨干比率方面表现出良好的重现性(p = 0.357);但在肿瘤斜率方面观察到显著差异(p < 0.05)。在峰值时间(p = 0.167)和纹状体斜率(p = 0.36)方面没有发现明显差异。结论:我们的框架有助于分析小儿脑肿瘤的 [18F]F-DOPA PET 图像,它能自动提取临床评分、简化分割和时间活动曲线提取、减少用户变异性并提高可重复性。
{"title":"A New Tool for Extracting Static and Dynamic Parameters from [<sup>18</sup>F]F-DOPA PET/CT in Pediatric Gliomas.","authors":"Michele Mureddu, Thomas Funck, Giovanni Morana, Andrea Rossi, Antonia Ramaglia, Claudia Milanaccio, Antonio Verrico, Gianluca Bottoni, Francesco Fiz, Arnoldo Piccardo, Marco Massimo Fato, Rosella Trò","doi":"10.3390/jcm13206252","DOIUrl":"https://doi.org/10.3390/jcm13206252","url":null,"abstract":"<p><p><b>Background/Objectives</b>: PET imaging with [<sup>18</sup>F]F-DOPA has demonstrated high potential for the evaluation and management of pediatric brain gliomas. Manual extraction of PET parameters is time-consuming, lacks reproducibility, and varies with operator experience. <b>Methods</b>: In this study, we tested whether a semi-automated image processing framework could overcome these limitations. Pediatric patients with available static and/or dynamic [<sup>18</sup>F]F-DOPA PET studies were evaluated retrospectively. We developed a Python software to automate clinical index calculations, including preprocessing to delineate tumor volumes from structural MRI, accounting for lesions with low [<sup>18</sup>F]F-DOPA uptake. A total of 73 subjects with treatment-naïve low- and high-grade gliomas, who underwent brain MRI within two weeks of [<sup>18</sup>F]F-DOPA PET, were included and analyzed. Static analysis was conducted on all subjects, while dynamic analysis was performed on 32 patients. <b>Results</b>: For 68 subjects, the Intraclass Correlation Coefficient for T/S between manual and ground truth segmentation was 0.91. Using our tool, ICC improved to 0.94. Our method demonstrated good reproducibility in extracting static tumor-to-striatum ratio (<i>p</i> = 0.357); however, significant differences were observed in tumor slope (<i>p</i> < 0.05). No significant differences were found in time-to-peak (<i>p</i> = 0.167) and striatum slope (<i>p</i> = 0.36). <b>Conclusions</b>: Our framework aids in analyzing [<sup>18</sup>F]F-DOPA PET images of pediatric brain tumors by automating clinical score extraction, simplifying segmentation and Time Activity Curve extraction, reducing user variability, and enhancing reproducibility.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11508825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142501325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1